Qatar Science & Technology Park (QSTP), a member of Qatar Foundation, has announced a strategic partnership with Merck to launch the QSTP x Merck FemTech Accelerator—a landmark initiative aimed at accelerating innovation in women’s health across the Middle East and North Africa.

The dedicated accelerator will identify and support up to 30 FemTech startups developing deep-tech, impact-driven solutions addressing critical unmet needs in women’s health. The programme focuses on advanced technologies, including artificial intelligence, robotics, and materials science, supporting startups from early validation through to commercial expansion.

Selected companies will gain access to QSTP’s innovation ecosystem and Merck’s global scientific and healthcare expertise, benefiting from curated mentorship, clinically aligned pilot opportunities, and structured market-entry pathways into Qatar, with scalability across regional and international markets. The accelerator is designed not only to support individual ventures, but also to generate measurable, trackable impact at scale, aligned with Qatar Foundation’s mission to improve health outcomes for women.

Through a multi-country approach, the accelerator enables FemTech solutions to be piloted, validated, and adopted across multiple markets, addressing women’s health challenges at both regional and global levels. Startups will also engage with key stakeholders from Qatar’s healthcare ecosystem, including clinicians, regulators, investors, and innovation leaders.

Commenting on the launch, Rama Chakaki, President of QSTP, said the accelerator reflects QSTP’s commitment to inclusive innovation and scalable impact. Meanwhile, Ahmed Aboelfadl, General Manager Gulf at Merck, highlighted the urgent need to address women’s health gaps through science- and technology-led solutions.

The programme includes an intensive two-week immersion in Doha, equipping founders with market insights, regulatory understanding, and commercial readiness. Together, QSTP and Merck aim to position Qatar as a regional and global hub for women’s health innovation, advancing one of the fastest-growing sectors in global health technology.